SEC Form 4 · accession 0001209191-17-022392
REVA Medical, Inc. · RVA:AX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey A. Anderson
Officer — SVP, Clinical & Regulatory
Period of report
Mar 20, 2017
Accepted (ET)
Mar 22, 2017 · 5:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496268
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 20, 2017 | A | 20,500 | $0.00 | A | 21,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $7.72 | Mar 20, 2017 | A | 41,000 | A | — | Mar 20, 2027 | Common Stock | 41,000 | 41,000 | D |
Explanation of responses
- F1Restricted stock units convert into common stock on a one-for-one basis. These restricted stock units shall vest annually on the anniversary date of the grant (March 20), with the first vesting occurring on March 20, 2018, at the rate of 33.3% annually, until fully vested.
- F225% of the shares vest on March 20, 2018, with the remaining shares vesting at 2.08333% per month thereafter until fully vested.